Bracco Diagnostics Inc. (United States) is linked to 5 FDA-registered manufacturing sites. 26 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Bracco Diagnostics Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/bracco-diagnostics-inc

Overview

Bracco Diagnostics Inc. is a subsidiary of Bracco Group, an Italian multinational active in the healthcare sector. The company specializes in diagnostic imaging, offering a range of products and solutions for X-ray, MRI, and ultrasound imaging.

Therapeutic areas

Diagnostic ImagingRadiology

Registered manufacturing sites (5)

Physical sites registered with the US FDA and resolved to Bracco Diagnostics Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

26 FDA enforcement records linked to this company.

  • 4832024-11-27

    Failure to develop written procedures

  • 4832024-11-27

    Late submission of 15-day report

  • recall — Class II2018-04-04

    Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.

  • 4832017-06-05

    Late submission of 15-day report

  • 4832014-05-30

    Failure to develop written procedures

  • 4832014-05-30

    Written control procedures

  • recall — Class III2014-02-19

    Failed Stability Testing: This product is below specification for preservative content.

  • recall — Class III2013-08-28

    Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.

  • recall — Class II2013-08-21

    Presence of foreign substance: One lot of the product may contain black foreign particles

  • 4832013-06-13

    Written QA procedures established, followed

  • 4832013-06-13

    Review of representative number of batches

  • 4832013-06-13

    Written specifications - components

  • 4832013-06-13

    Investigations of discrepancies, failures

  • 4832013-06-13

    Procedures not in writing, fully followed

  • 4832013-06-13

    input/output verification

  • recall — Class II2012-10-03

    GMP deviation; Sr-82 levels exceeded alert limit specification

  • recall — Class II2012-09-05

    Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.

  • recall — Class III2012-09-05

    Short Fill: The product is being recalled due to a potential underfill of the affected vials.

  • 4832012-07-27

    Computer control of master formula records

  • 4832012-07-27

    Investigations of discrepancies, failures

  • 4832012-07-27

    Procedures not in writing, fully followed

  • 4832012-07-27

    Review of representative number of batches

  • 4832012-07-27

    Written QA procedures established, followed

  • 4832012-07-27

    Written record of complaint to include findings, follow-up

  • 4832012-07-27

    Written complaint procedures

  • warning_letter2012-01-31

    FDA Warning Letter (drug product)

For suppliers

Is this Bracco Diagnostics Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.